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Post-translational modiﬁcation (PTM) modulates and supplements protein functionality. In nature this high
precision event requires speciﬁc motifs and/or associated modiﬁcation machinery. To overcome the
inherent complexity that hinders PTM's wider use, we have utilized a non-native biocompatible Click
chemistry approach to site-speciﬁcally modify TEM b-lactamase that adds new functionality. In silico
modelling was used to design TEM b-lactamase variants with the non-natural amino acid p-azido-L-
phenylalanine (azF) placed at functionally strategic positions permitting residue-speciﬁc modiﬁcation
with alkyne adducts by exploiting strain-promoted azide–alkyne cycloaddition. Three designs were
implemented so that the modiﬁcation would: (i) inhibit TEM activity (Y105azF); (ii) restore activity
compromised by the initial mutation (P174azF); (iii) facilitate assembly on pristine graphene (W165azF). A
dibenzylcyclooctyne (DBCO) with amine functionality was enough to modulate enzymatic activity.
Modiﬁcation of TEMW165azF with a DBCO–pyrene adduct had little eﬀect on activity despite the
modiﬁcation site being close to a key catalytic residue but allowed directed assembly of the enzyme on
graphene, potentially facilitating the construction of protein-gated carbon transistor systems.Introduction
Post-translational modication (PTM) is central to biology by
expanding and modulating the function of a large number of
proteins.1 Many of these events essentially permanently cova-
lently modify a protein, ranging from attachment of small
moieties (e.g. methylation,2 cofactors3) to larger events such as
proteolysis and glycosylation. Each of these factors can impact
signicantly on protein structure and function thus inuencing
and even enabling inherent protein activity. The presence of
sequence and/or structural motifs in combination with of a
wide variety of subsidiary machinery, mostly enzymes, is
required to achieve exquisite specicity both in terms of the
target protein and the spatial position in the modied target.
The complexity of these systems can be a signicant hindrance
with respect to their transfer to new proteins where such PTMs
are not inherent. Furthermore, PTM is largely restricted to a
select chemical set preexisting in nature. Precise modicationardiﬀ, UK. E-mail: jonesdd@cardiﬀ.ac.uk
niversity, Cardiﬀ, Wales, UK
Exeter, Exeter, Devon, UK
(ESI) available: Detailed experimental
supplementary Tables 1 to 3. See DOI:
to this work.with non-natural adducts may be a more appropriate and useful
means to expand and modulate protein function,4,5 including
for use in non-biological contexts.
Covalent modication with non-natural adducts is tradi-
tionally achieved using chemistry inherent to the natural amino
acid repertoire, mostly amine, carboxyl and thiol groups. The
main problem is lack of specicity as such chemistry is nor-
mally distributed across the surface of a protein and is ubiq-
uitous in the proteome. A more general and powerful approach
is the introduction of new chemically reactive handles not
present in the native 20 amino acid set through the use of an
expanded genetic code6 (see ref. 7–10 for recent reviews). The
unique reactivity of a chosen non-natural amino acid (nAA)
together with the ability to select both the target protein and the
residue within the target means that specicity comparable to
natural PTM events can be achieved.10,11 The use of highly
specialized caged nAAs has been very eﬀective in controlling
activity12–15 but is restricted to certain protein types and chem-
istry, and can add signicant bulk to the amino acid side chain
during the production and folding of the nascent polypeptide
and its subsequent folded form.
The incorporation of phenyl azide chemistry into proteins
through the use of p-azidophenylalanine (azF)17 is an attractive
alternative. As well as being only one atom bigger than the
natural amino acid tyrosine and having been successfully
incorporated into a wide variety of proteins,7–9 the phenyl azideThis journal is © The Royal Society of Chemistry 2015
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View Article Onlinemoiety opens up diﬀerent routes to non-natural PTM (nnPTM):
photochemical transformations and Click chemistry adduct
addition.9 The use of phenyl azide photochemistry to control
protein activity has recently been demonstrated.18–22 Azide–
alkyne cycloaddition is fast becoming a useful approach for
orthogonal biomolecule conjugation but has largely been used
in a passive way, for example, to label proteins.7,23–25 Given the
versatility in terms of the array of adducts available coupled
with the inherent bioorthogonality and biocompatibility,26 it is
surprising Click chemistry has not been used more extensively
as a general direct modulator of protein activity. Additionally,
useful adducts can be placed at strategic positions to expand
and facilitate protein function in a manner akin to co-factors.
This includes attachment of entities to facilitate interfacing and
assembly with secondary systems or materials.27–31 As in many
natural biomolecular assemblies, a dened and optimal
protein–material interface is critical for maximal communica-
tion between the individual elements. Interfacing proteins with
carbon sp2 materials such as graphene is gaining signicant
interest as it forms the basis for constructing hybrid bio-tran-
sistors in which events at even the single protein molecule level
can be used to gate conductance through graphene.27,32Fig. 1 Modiﬁcation of TEM b-lactamase. The structure of TEM b-
lactamase (top left) with the inhibitor imipenem (yellow sticks to
emphasise the substrate binding pocket) highlights the residues tar-
geted for replacement with azF (red spheres) together with the key
catalytic residues (cyan sticks) and the U-loop (green). The protein
structures were generated using PyMol.16 A representation of the
SPAAC reaction using the activated alkyne present in the core DBCO
moiety is shown (top right). The R groups attached to the DBCO used
in this study are shown (bottom half).
This journal is © The Royal Society of Chemistry 2015Here, we show that the activity and assembly onto pristine
graphene of the antibiotic resistance protein TEM b-lactamase33,34
can be directly controlled by Click chemistry. By genetically
encoding phenyl azide chemistry at designed positions in TEM
and using Cu-free biocompatible strain promoted azide–alkyne
cycloaddition (SPAAC; Fig. 1)35,36 diﬀerent adducts can be attached
(1, 2 and 3; Fig. 1) that either reduce or restore activity on modi-
cation, and dene assembly of TEM on graphene.Results and discussion
The three main adducts with a core dibenzylcyclooctyne (DBCO)
reactive handle (Fig. 1) chosen have very distinct properties: 1 is
an amine derivative of DBCO that has hydrogen donor and
acceptor groups opening up the potential to form H-bonds
between residues not normally close enough to each other in the
protein structure; 2 is a large, planar and hydrophobic rhoda-
mine dye (Texas Red) that has proved useful in labelling proteins
for uorescent imaging23 but could also act as an eﬀective bulk
spatial and steric blocking element if required; 3 is a pyrene
derivative that will aid protein interfacing with extended carbon
sp2 materials (e.g. graphene) through p–p stacking.29,37 Both 1
and 2 are “oﬀ-the-shelf” products while 3 can be generated by a
simple succinimidyl ester reaction. Thus, all 3 adducts can easily
be accessed by the wider bioscience community without any
synthetic chemistry knowledge. The azF dependent production of
active enzyme is shown in ESI Fig. 1.†Modulating enzyme activity
The in silico design process was performed using a combination
of ROSETTA38 and molecular dynamics39 as outlined in the Sup-
porting Methods.† Y105, a partially surface exposed residue
(110 A˚2z 50% relative surface exposure), was chosen as a site
for negative modulation through nnPTM due to its location close
to the catalytically important SDN loop and its role in forming a
partial lid over substrate binding cle (Fig. 1; ESI Fig. 2†). Y105 is
thought to be especially important in dening the size of the
substrate binding cle (therefore substrate specicity)40 and local
dynamics of residues critical for activity.41 In silico modelling
predicted exchanging the hydroxyl group for an azide should not
have a major eﬀect on enzyme structure around the locality of
residue 105 (Fig. 2a). In fact ampicillin hydrolysis was slightly
enhanced (higher kcat) for TEM
Y105azF but had a slightly lower
aﬃnity (higher KM) making overall catalytic eﬃciency similar to
wt TEM (Fig. 3 and ESI Table 1†). TEMY105azF was receptive to
modication by SPAAC as indicated by the estimated labelling
eﬃciency of 80% with 2.
As predicted, TEMY105azF was largely inhibited on modica-
tion with either 1 or 2 (Fig. 3) despite neither having any
signicant inherent inhibitory eﬀect on wild-type TEM (ESI
Table 1†). Both catalysis and substrate binding were disrupted
as evident by the decrease in kcat and increase in KM (ESI Table
1†) for ampicillin resulting in an overall decrease in catalytic
eﬃciency of 70% and 85% when modied with 1 or 2
respectively compared to unmodied protein. This is similar to
the most deactivating site-directed mutants of Y105.40Chem. Sci., 2015, 6, 3712–3717 | 3713
Fig. 2 Molecular design models of TEM azF variants. (A) Model of
TEMY105azF (yellow) aligned with wt TEM b-lactamase (grey; PDB 1btl),
with the active site S70 shown as stick representation. (B) Alignment of
the TEMP174azF (cyan) with wt TEM (grey; PDB 1btl). The region high-
lighted in red covers residues 173–175. (C) Interaction of AzF174 with
neighbouring residues.
Fig. 3 Enzyme kinetics of ampicillin hydrolysis by TEM b-lactamase
variants pre- and post-Click modiﬁcation. (A) Catalytic eﬃciency of
each variant before and after modiﬁcation with 1 (+1) or 2 (+2) derived
from KM and kcat (ESI Table 1†). (B) The eﬀect of modifying TEM
P174azF
with 1 (Click 1) or 2 (Click 2) on Michaelis–Menten kinetics. (C)
Modelled changes to backbone structure of TEMP174azF (cyan) on
modiﬁcation with 1 (green) compared to wt TEM (grey) (top panel) and
the conﬁguration and local interactions (hydrogen bond in red) of 1
(bottom panel).
Chemical Science Edge Article
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
1 
M
ar
ch
 2
01
5.
 D
ow
nl
oa
de
d 
on
 1
2/
11
/2
01
5 
11
:1
8:
24
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article OnlineModelling of the covalent complex (vide infra) between
TEMY105azF and 1 suggested that modication blocks access at
one end of the substrate binding site, with the amine of 1
forming a hydrogen bond with the backbone carbonyl group of
G238 (ESI Fig. 3†). The enzyme kinetics suggests that simple
steric blocking of substrate binding is unlikely to be the sole
mechanism of action as catalysis and substrate binding are
equally aﬀected, similar to that observed for classical mixed3714 | Chem. Sci., 2015, 6, 3712–3717inhibition models. The relatively small diﬀerence in catalytic
eﬃciency of TEMY105azF modied with either 1 or 2 indicates
that the most signicant eﬀect is occurring close to the linkage
site, as suggested by the covalent complex model (ESI Fig. 3†).
However, the bulkier group of 2 is exerting a slightly greater
eﬀect with regards to kcat rather than KM (Fig. 3 and ESI Table
1†) suggesting that long range interactions made by the
rhodamine dye moiety may be forcing the structure around
residue 105 to adapt less catalytically procient form. Currently,
the separation of modied from unmodied protein has proved
unsuccessful, so the observed activity may be contributed by
unmodied protein only (estimated to be 20%; vide supra).
Therefore, the inhibition levels observed here represent the
lowest currently achievable and we cannot rule out modied
species are essentially inactive.
P174 is another largely surface exposed residue (80 A˚2 z
60% relative surface accessibility) that is relatively distant from
the active site (Fig. 1). P174 however contributes towards one of
the turns that comprise the U loop (Fig. 1 and ESI Fig. 4†), a
region critical for substrate binding, substrate specicity and
catalysis.42,43 It was hypothesized in the design process that
mutating P174 to a non-cyclic amino acid would result in local
conformational changes around the turn region. Molecular
modelling supported this hypothesis with the structure of the
turn slightly shied compared to wt TEM (Fig. 2b and ESI
Fig. 5†). The side chain of azF174 lies approximately perpen-
dicular to the native proline, with the azido moiety tting into a
shallow pocket and making a local polar interaction network
with R42 and T265 (Fig. 2c). These new interactions may act as
the driver of local conformation changes associated with the
P174azF mutation, which in turn alters the local bonding
network that subtly shis the conformation of both the active
site and substrate binding residues, including S70 (ESI Fig. 5†).
Based on the TEMP174azF model it was further postulated that on
modication with 1, the formation of the triazole link would
break the interaction network with R42 and T265 so recon-
stituting the original loop structure and activating the protein.
The amine group also has the potential to form new long range
hydrogen bonds in spatially local regions (Fig. 3 and ESI
Fig. 4†).
As suggested by the model, replacement of P174 with azF
results in a signicant change in activity. The overall catalytic
eﬃciency of TEMP174azF was 60% lower compared to wt TEM
(Fig. 3). The major eﬀect was on kcat which was 3 fold lower
compared to wt TEM (ESI Table 1†), supporting the evidence
from the model that the likely eﬀect of azF incorporation at
residue 174 is to disrupt interactions of residues associated with
catalysis. This was oﬀset by a slightly increased ampicillin
aﬃnity.
TEMP174azF was accessible to Click modication, but eﬃ-
ciency was lower (estimated 33% using the absorbance prop-
erties of 2) compared to TEMY105azF. It is unknown how local
protein microenvironment dictates SPAAC eﬃciency but
dynamics, relative exposure to aqueous solvent and the char-
acter of shallow “pockets” have been suggested as possible
determinants.23 The molecular model suggests that interaction
of the azide moiety with other residues, which may play a roleThis journal is © The Royal Society of Chemistry 2015
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View Article Onlinethrough, for example, altering the relative populations of reso-
nance structures sampled by the azide moiety (R–N]N+]N/
R–N–N+^N), and/or its accessibility and available orientations
to the incoming DBCO. The eﬀect of the SPAAC nnPTM on the
ability of TEMP174azF to hydrolyse ampicillin varied depending
on the DBCO adduct. Modication with 2 exerted a similar but
somewhat smaller inhibitory eﬀect (40% drop) as observed for
TEMT105azF (Fig. 3 and ESI Table 1†). Modication with 1
resulted in a signicant increase in overall activity restoring
apparent catalytic eﬃciency essentially to wild-type levels
(Fig. 3). This should be considered as a lower estimate of acti-
vation as 70% of the protein may be unmodied (vide supra).
With both adducts, the most signicant contribution was the
change in kcat of TEM
P174azF compared to unmodied protein
(ESI Table 1†); modication with 1 increased kcat by 210% while
addition of 2 reduced kcat by almost half.
To understand how 1 exerts its benecial eﬀect on TEMP174azF,
the nnPTM product was modelled. Using the TEMP174azF model
as a starting point, the triazole linkage between azF and DBCO of
1 was generated in silico by parameterizing the azF–DBCO
complex to calculate optimized geometries and the electrostatic
potentials. The model was subjected to molecular dynamics for a
total of 5 ns. The model of nnPTM product, termed TEMP174azF+1
suggested that the general structure was closer to wt TEM than
the original TEMP174azF model (Fig. 3c and ESI Fig. 5†). The U-
loop structure around residue 174 and the local bonding
networks for TEMP174azF+1 were largely comparable with wt TEM.
The orientation of residue 174 diﬀers signicantly to accommo-
date 1 (ESI Fig. 5†). The amine group of 1 bends back and appears
to come within hydrogen bonding distance (2.6 A˚) of the side-
chain carbonyl group of the adjacent residue N175 (Fig. 3c). The
loss of the azide group on formation of the trizole removes the
interactions with R43 and T238. However, the reason for 1 acting
as an activator and 2 as an inhibitor may be down to the reduced
bulk and ability of 1 to form local H-bonds.Fig. 4 AFM imaging of pyrene-modiﬁed TEMW165azF on graphene. (A)
Model of TEMW165azF (magenta) modiﬁedwith 1 alignedwith the crystal
structure of wt TEM (grey) with the residues either side of residue 165
and the catalytic S70 highlighted. The surface representation of
TEMW165azF modiﬁed with 1 (left panel) illustrates that the Click adduct
points out and away from the protein. Repeated AFM imaging of the
surface after the (B) sixth and (C) tenth scans shows that the proteins
bind stably to the surface. The height analysis of a single TEMW165azF-3
molecule, which is selected in C (highlighted as *) is shown as an inlay
to C. ESI Movie 1† provides a full trace for the imaged area above over
10 scans.Protein–graphene interfacing
In some instances, it would be attractive to select a residue
intimately associated with active site regions so that secondary
non-related events can be coupled to activity without signicant
eﬀect on function. Linking proteins to carbon sp2 materials
such as graphene is especially attractive; local charge and
electrostatic changes in the protein can be used to “gate” the
electronic properties of the sp2 material27,44 so generating
sensing systems with ultimate single molecule resolution. The
pyrene moiety of 3 (Fig. 1) is especially attractive as an inter-
facing agent as it allows dened coupling of a protein to the sp2
material through p stacking.37 This has been demonstrated
previously using optimally placed cysteine residues as the
reactive handle for attachment to pyrene-coated single walled
carbon nanotubes.27 However, this required removal by muta-
genesis of native cysteine residues. Here, we demonstrate that
dened enzyme interfacing on a clean graphene face is feasible
though the use of designed azF placement.
W165 is another partially surface exposed residue (100 A˚2
z 50% relative surface accessibility) that fulls the requiredThis journal is © The Royal Society of Chemistry 2015criteria (Fig. 1). It resides in the U-loop and splits two func-
tionally important residues; E166 is a conserved catalytic
residue involved in proton shuttling34 and R164 forms buried
ionic interactions critical for stabilizing the U loop and thus the
positioning of E166.45 The approach used to model TEMP174azF
modied with 1 was applied to the W165azF mutation to
ascertain the potential position of the adduct group and its
eﬀect on structure (Fig. 4a). Modelling suggested that the
overall structure of the protein would be largely unperturbed
and the adduct would point outwards into the solvent. Mutating
W165 to azF did slightly reduce overall catalytic eﬃciency
towards ampicillin (1.5 fold) but crucially, modication with 3
was feasible and had little eﬀect on overall activity (ESI Fig. 6†).
By coupling 3 to TEMW165azF prior to surface assembly we can
directly interface the protein with graphene in a dened
manner without surface coating with pyrene, as has been
previously used.27,46 Intermittent-contact mode AFM (tapping
mode) imaging indicated that TEMW165azF modied with pyrene
binds stably to graphene surfaces (Fig. 4b and c; ESI Fig. 7 &
Movie 1†). The protein molecules are not signicantly disturbed
by multiple scans. The average apparent heights were 3 nm,
which is close to the predicted height of the protein bound in
the designed orientation (3 nm; ESI Fig. 7†). The average
apparent lateral dimension was larger than predicted (10 nm
versus 5 nm), as a result of tip convolution eﬀects. In compar-
ison, wt TEM did not stably bind to the surface, with tip
contamination commonly observed aer multiple scans (ESI
Fig. 8†).Chem. Sci., 2015, 6, 3712–3717 | 3715
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View Article OnlineConclusions
SPAAC is a powerful approach for precise and designed protein
PTM that supplement protein activity using a non-intrusive,
non-caged reaction handle. We have demonstrated here that
SPAAC can be used beyond simple passive labelling of proteins
and can actively modulate activity through diﬀerent mecha-
nisms without the need to synthesize specialized molecules. It
also facilitates the interfacing of proteins in a designed and
dened manner with useful active materials such as graphene.
This negates the need to remove inherent chemistry through
mutagenesis allowing the focus to be on placing the reactive
handle for optimal coupling between the protein and material.
In silico modelling with both nAA and adducts can greatly aid
the design process by which useful variants are generated and
their aﬀects rationalised, which will in turn lead to more
accurate designs.Experimental
In silico protein modelling
A detailed description of the in silico modelling of TEM con-
taining the azF mutation and modication with the DBCO-
amine adduct (1) are provided in the ESI.† Briey, geometry
optimised structure les, force eld parameters for azF and
azF–DBCO amine adduct complexes were generated. The pub-
lished crystal structure of TEM b-lactamase to 1.8 A˚ resolution
(PDB code 1BTL45) was used as a starting point for Monte Carlo
simulations within the ROSETTA soware package.38 The lowest
energy model was used as the starting point for molecular
dynamics using GROMACS.39 The modelling was run on the
Raven cluster as part of the Advanced Research Computing @
Cardiﬀ facility.Enzyme activity assays
The wt and mutant TEM variants were generated as outlined in
the ESI.† The proteins were expressed in E. coli using a bespoke
plasmid based on pBAD called pBADKAN, and puried as
described in the ESI.† The TEM-dependent kinetics of ampi-
cillin hydrolysis (3235 ¼ 1500 M1 cm1) were determined
spectrophotometrically using 1 cm path length QS quartz
cuvette (Hellma). Hydrolysis assays were carried out in a 1 mL
reaction volume. Puried enzyme was diluted to a nal
concentration of 250 ng mL1 in 50 mM sodium phosphate
buﬀer, pH 8 at room temperature. Reactions were started by
addition of ampicillin and hydrolysis was measured by the
decrease in absorbance at 235 nm. Ampicillin concentrations
ranged from 50 mM to 800 mM. Kinetic parameters were calcu-
lated using initial rate of hydrolysis at each substrate concen-
tration and then tting to theMichaelis–Menten equation using
GraphPad Prism. TEM b-lactamase activity using the colori-
metric substrate nitrocen was performed essentially as
described previously.47,483716 | Chem. Sci., 2015, 6, 3712–3717Click modication
SPAAC reactions were performed on pure protein using a ve-
fold molar excess of dibenzylcyclooctyne (DBCO) reagent to
protein. DBCO-amine (1) and DBCO–Fluor 585 (2) were
obtained from Click chemistry tools, while DBCO–pyrene was
synthesized from DBCO-amine and 1-pyrenebutanoic acid,
succinimidyl ester via nucleophilic substitution. Reactions were
le overnight at room temperature in PBS. SPAAC reactions
with 2 were analysed by SDS-PAGE and subsequent imaging of
the uorescent dye on a transilluminator. Labelling eﬃciencies
were calculated as described in the ESI.†
Protein deposition on graphene and AFM imaging
Protein samples were deposited onto graphene on a copper foil
substrate. Monolayer graphene was deposited on the copper
substrate by chemical vapor deposition (CVD) using methane as
carbon source. A detailed description of the growth procedure is
provided in the ESI.† The foil pieces (4 mm2) were immersed
in PBS containing 1 nM protein and incubated at room
temperature for 10 min. Following incubation, the foil pieces
were rinsed with high purity deionised water and dried with N2
gas. AFM imaging was performed in using a Veeco Nanoscope
IIa (Bruker) in tapping mode. The same area was scanned up to
10 times with a total of 6 diﬀerent regions imaged to check the
stability of the protein molecules on the surface of graphene. A
video of the surface scans is provided as ESI.† Although the
images show some dri, it is clear that the proteins are stably
bound to the surface.
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